Law Daily Report

Stealth BioTherapeutics' neuromuscular disorder drug fails late-stage study

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 66%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

REUTERS: Stealth BioTherapeutics Corp said on Friday its drug to treat neuromuscular diseases failed to meet the main goals of a late-stage trial.

The trial was testing the drug, elamipretide, to treat patients with primary mitochondrial myopathy, but failed to help patients walk better and reduce fatigue, the company said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

US House impeachment of Trump sets stage for trial in SenateWASHINGTON: The impeachment of President Donald Trump in the US House of Representatives on charges of abuse of power and obstruction of Congress ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »